Categories: Company News

GMP CERTIFICATION FOR BIOCAD IN UKRAINE

New Delhi November 23,2013:

Biocad is a biopharmaceutical company, is a leader in Russian companies when it comes to the number of trials conducted. The company has a well established laboratory and equipment. Biocad is involved in development of biotechnological products that range from genetic engineering to preclinical testing.

Biocad, this week was successful in obtaining a good manufacturing practice (GMP) certificate in Ukraine. This certificate proves to be important for the company. It confirms that the company’s manufacturing plant in Moscow region meets the standards good manufacturing practice (GMP) norms.

The company deals with biological and biotech products. The areas in which it predominantly focuses include reproductive health, autoimmune health, viral infection and hematology and oncology. The company has clinical research studies being conducted in countries like Russia, Ukraine, India and Belarus. CCI Newswire

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago